FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

18051111000001107: Augmentin 375mg tablets (Lexon (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Nov 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62143101000001117 Augmentin 375mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62143201000001112 Augmentin 375mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Augmentin 375mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Is a Co-amoxiclav 250mg/125mg tablets true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Is a Co-amoxiclav 250mg/125mg tablets false Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Is a Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Is a Augmentin true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 375mg tablets (Lexon (UK) Ltd) Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Augmentin 375mg tablets (Lexon (UK) Ltd) 21 tablet Has AMP True Augmentin 375mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start